V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021462 | 220014398 | null | 55.95 | Curative (C) | 2016-11-03 | 2016-11-03 | FLAG | null | N | 220030624 | FLAG |
| 220021463 | 220008035 | null | 56.7 | Not known (9) | 2015-01-11 | 2015-03-22 | RUXOLITINIB | N | null | 220030630 | RUXOLITINIB |
| 220021464 | 220014402 | 1.84 | 72.2 | Palliative (P) | 2018-10-02 | 2018-10-08 | FLAG | 2 | N | 220030653 | FLAG |
| 220021465 | 220017861 | 1.56 | 13.9 | Curative (C) | 2016-02-01 | 2016-02-01 | AML16 Low Dose Cytarabine | N | N | 220030685 | AML16 TRIAL |
| 220021466 | 220008089 | 1.53 | null | Curative (C) | 2014-11-12 | 2014-11-12 | FLAG | N | N | 220030766 | FLAG |
| 220021469 | 220017873 | 1.59 | 57.4 | Disease modification (D) | 2014-02-15 | 2014-02-15 | IDARUBICIN + TRETINOIN | N | N | 220030849 | IDARUBICIN + TRETINOIN |
| 220021470 | 220008117 | 1.63 | 55 | Curative (C) | 2018-05-30 | 2018-07-19 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 220030880 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220021472 | 220008144 | 1.68 | 89 | Curative (C) | 2018-12-05 | 2018-12-16 | FLAG | 02 | N | 220030955 | FLAG |
| 220021474 | 220008154 | 1.78 | 133.5 | Disease modification (D) | 2014-03-20 | 2014-07-25 | Triple / Double Intrathecal Therapy | null | null | 220030962 | TRIPLE INTRATHECAL |
| 220021476 | 220008170 | 1.75 | 72.5 | Disease modification (D) | 2013-08-01 | 2013-08-08 | AML Int Guide ADE 10+3+5 (1) | N | N | 220031002 | ADE |
| 220021477 | 220017893 | 1.73 | 59.9 | Curative (C) | 2018-06-11 | 2018-06-12 | Fludarabine + Melphalan RIC Allo | 02 | N | 220031027 | ECX |
| 220021478 | 220008180 | 1.75 | 70.7 | Palliative (P) | 2016-12-06 | 2016-12-07 | Docetaxel | N | N | 220031046 | CISPLATIN + GEMCITABINE |
| 220021480 | 220008237 | 1.76 | 71.6 | Curative (C) | 2013-03-19 | 2016-08-23 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | null | N | 220031299 | DOCETAXEL |
| 220021481 | 220008241 | 1.64 | null | Curative (C) | 2015-03-19 | 2015-03-19 | Arsenic Triox + Tretinoin Ind W5-8 | 02 | N | 220031302 | ARSENIC TRIOXIDE + TRETINOIN |
| 220021482 | 220008253 | 1.69 | null | Curative (C) | 2015-05-31 | 2015-10-21 | PONATINIB | Y | null | 220031392 | FLUDARABINE + MELPHALAN |
| 220021483 | 220008263 | 1.9 | 93 | Curative (C) | 2018-02-01 | 2018-02-03 | CARBOPLATIN + PACLITAXEL | 02 | Y | 220031415 | CARBOPLATIN + PACLITAXEL |
| 220021484 | 220008284 | 1.75 | null | Curative (C) | 2018-08-11 | 2018-09-08 | Clofarabine + Cytarabine | Y | N | 220031482 | UKALL2014 |
| 220021485 | 220008289 | 1.73 | 66 | Curative (C) | 2018-07-16 | 2018-07-17 | PONATINIB | 02 | null | 220031491 | FBC |
| 220021486 | 220008319 | 1.82 | 56.6 | Curative (C) | 2014-11-25 | 2014-12-13 | Clofarabine + Cytarabine | N | N | 220031606 | OXALIPLATIN + MDG |
| 220021487 | 220008322 | 1.69 | 77.8 | Curative (C) | 2013-07-23 | 2013-08-16 | GEMTUZUMAB OZOGAMICIN | 2 | N | 220031607 | METHOTREXATE |
| 220021488 | 220021905 | 1.98 | 88.1 | Curative (C) | 2016-12-13 | 2016-12-13 | Clofarabine + Cytarabine | null | null | 220031681 | PONATINIB |
| 220021489 | 220008347 | 1.7 | 52.6 | Disease modification (D) | 2014-06-11 | 2014-06-12 | Carboplatin + Etoposide iv&po | N | N | 220031687 | CARBOPLATIN + ETOPOSIDE |
| 220021490 | 220008353 | null | null | Palliative (P) | 2017-02-09 | 2018-01-06 | ECX | N | N | 220031700 | FLUDARABINE + MELPHALAN |
| 220021491 | 220008359 | 1.62 | 88.3 | Curative (C) | 2013-02-24 | 2014-01-24 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 220031735 | CARBOPLATIN + PACLITAXEL |
| 220021493 | 220008389 | 1.69 | 102.6 | Curative (C) | 2017-01-13 | 2019-03-02 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220031813 | DOCETAXEL |
| 220021494 | 220008392 | 1.65 | 71 | Palliative (P) | 2015-02-01 | 2015-02-02 | Fludarabine + Melphalan RIC Allo | N | N | 220031821 | DOCETAXEL |
| 220021495 | 220008410 | 1.67 | 62.7 | Curative (C) | 2014-04-01 | 2014-04-07 | Irinotecan + De Gramont | N | N | 220031924 | CISPLATIN + GEMCITABINE |
| 220021497 | 220008420 | 1.79 | 60 | Curative (C) | 2017-04-26 | 2017-04-27 | Mitox + Tretinoin Spanish Course 3 | Y | null | 220031947 | MITOXANTRONE |
| 220021498 | 220008426 | null | 55 | Disease modification (D) | 2018-03-04 | 2018-03-11 | UKALL14- Ph 1 Induction | 02 | N | 220031977 | METHOTREXATE |
| 220021499 | 220008428 | 1.57 | 71.45 | Curative (C) | 2016-07-18 | 2016-10-22 | Oxaliplatin + Modified de Gramont | 2 | N | 220031998 | FLUDARABINE + MELPHALAN |
| 220021500 | 220008435 | 1.55 | 52.8 | Curative (C) | 2017-09-24 | 2017-10-05 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220032025 | ALEMTUZUMAB |
| 220021501 | 220008443 | 1.72 | 0 | Curative (C) | 2017-09-23 | 2017-09-23 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220032039 | GEMCARBO |
| 220021502 | 220008448 | 1.71 | 96.45 | Curative (C) | 2017-07-22 | 2017-07-22 | Cytarabine intrathecal | N | N | 220032050 | CYTARABINE INTRATHECAL |
| 220021503 | 220008461 | 1.78 | 63.1 | Curative (C) | 2018-06-08 | 2018-06-08 | GemCarbo Days 1+8 | 02 | N | 220032072 | PONATINIB |
| 220021504 | 220008466 | 0 | 112.8 | Curative (C) | 2016-04-14 | 2016-09-15 | Mitoxantrone | 02 | N | 220032105 | MITOXANTRONE |
| 220021505 | 220014589 | 1.66 | 66.8 | null | 2014-03-31 | 2014-04-19 | Docetaxel 75mg/m2 (21 day) | 2 | N | 220032108 | CISPLATIN + GEMCITABINE |
| 220021506 | 220008481 | 1.83 | 72 | Curative (C) | 2013-06-12 | 2014-06-03 | METHOTREXATE | N | N | 220032113 | GEMTUZUMAB OZOGAMICIN |
| 220021507 | 220008485 | 1.8 | 76 | Curative (C) | 2015-08-02 | 2015-08-03 | METHOTREXATE | 2 | N | 220032126 | CISPLATIN + GEMCITABINE |
| 220021508 | 220008494 | 1.56 | null | Curative (C) | 2015-01-16 | 2015-01-19 | Carboplatin + Etoposide IV 3 day | 02 | N | 220032156 | CARBOPLATIN + ETOPOSIDE |
| 220021509 | 220008501 | 1.65 | 0 | Curative (C) | 2015-09-12 | 2015-11-13 | Methotrexate + Folinic acid | Y | N | 220032158 | OXALIPLATIN + MDG |
| 220021510 | 220008505 | 1.8 | 108 | null | 2013-07-02 | 2014-04-02 | GemCarbo Days 1+8 | N | N | 220032159 | DOCETAXEL |
| 220021511 | 220008525 | 1.73 | 84.9 | null | null | 2015-03-26 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 2 | N | 220032227 | ECX |
| 220021512 | 220008529 | 2 | 57 | Palliative (P) | 2016-05-10 | 2016-10-27 | CISPLATIN + GEMCITABINE | N | N | 220032251 | PONATINIB |
| 220021514 | 220008545 | 1.73 | 97 | Adjuvant (A) | 2014-01-02 | 2014-05-03 | IDARUBICIN | null | null | 220032272 | IDARUBICIN |
| 220021515 | 220008586 | 0 | 96.45 | Curative (C) | 2017-03-30 | 2017-04-03 | PONATINIB | N | N | 220032405 | GEMCARBO |
| 220021516 | 220008590 | null | 66.2 | Palliative (P) | 2014-07-04 | 2014-07-04 | PONATINIB | N | N | 220032418 | FLUDARABINE + MELPHALAN |
| 220021517 | 220008601 | null | 78 | Curative (C) | 2017-10-10 | 2017-10-24 | UKALL14- Ph 2 Induction | N | N | 220032464 | OXALIPLATIN + MDG |
| 220021518 | 220008605 | 1.52 | 61.3 | Curative (C) | 2015-11-11 | 2016-02-17 | UKALL14- Ph 1 Induction + Imatinib | N | N | 220032477 | IRINOTECAN + MDG |
| 220021519 | 220014652 | 1.57 | 68 | Curative (C) | 2016-07-11 | 2016-07-19 | GEMTUZUMAB OZOGAMICIN | N | N | 220032532 | ECX |
| 220021520 | 220008635 | 1.73 | 86.75 | Curative (C) | 2014-10-14 | 2015-01-11 | GEMTUZUMAB OZOGAMICIN | N | N | 220032602 | METHOTREXATE |